Delivery Order SPE2DB20D1100-SPE2DB25FE1KD
- Not listed
- The Defense Logistics Agency awarded a $11,522.91 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on September 12, 2025, with completion scheduled for September 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $123,893.32 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a completion date of September 10, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. The order will be fulfilled from the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $28,041.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S inhalers, with a completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $6,220.79 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order under a competitive award with no set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $34,278.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitive award with an ultimate completion date of September 15, 2025, and performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,076.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $5,773.90 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) valued at $101,693.21. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Trelegy...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1KDDelivery Order
The Defense Logistics Agency awarded a $11,102.78 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with performance occurring at its corporate office location. The delivery order falls within the scope of AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which covers a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Trelegy Ellipta is a combination respiratory maintenance therapy prescribed for chronic obstructive pulmonary disease management, reflecting the company's role in supplying essential medications to support Defense Health Agency operations and other federal healthcare systems. The contract structure demonstrates AmerisourceBergen's capability to fulfill federal medical procurement requirements through open competition and flexible delivery mechanisms across the global military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/26/25 |